| Primary |
| Cerebral Infarction |
20.0% |
| Peripheral Arterial Occlusive Disease |
12.4% |
| Hypertension |
8.6% |
| Lacunar Infarction |
5.7% |
| Pneumonia |
5.7% |
| Brain Stem Infarction |
4.8% |
| Diabetes Mellitus |
4.8% |
| Cardiac Failure Chronic |
3.8% |
| Insomnia |
3.8% |
| Angina Pectoris |
2.9% |
| Atrial Fibrillation |
2.9% |
| Benign Prostatic Hyperplasia |
2.9% |
| Carotid Artery Stent Insertion |
2.9% |
| Cerebellar Infarction |
2.9% |
| Depression |
2.9% |
| Gastritis |
2.9% |
| Prophylaxis |
2.9% |
| Thrombosis In Device |
2.9% |
| Thrombosis Prophylaxis |
2.9% |
| Arterial Injury |
1.9% |
|
| Death |
7.3% |
| Palpitations |
7.3% |
| Ventricular Fibrillation |
7.3% |
| Blood Creatine Phosphokinase Increased |
4.9% |
| Large Intestinal Ulcer |
4.9% |
| Loss Of Consciousness |
4.9% |
| Melaena |
4.9% |
| Pyrexia |
4.9% |
| Renal Disorder |
4.9% |
| Renal Failure Acute |
4.9% |
| Shock |
4.9% |
| Subarachnoid Haemorrhage |
4.9% |
| Subdural Haematoma |
4.9% |
| Thrombosis |
4.9% |
| Thrombosis In Device |
4.9% |
| Upper Gastrointestinal Haemorrhage |
4.9% |
| Vascular Pseudoaneurysm |
4.9% |
| Ventricular Tachycardia |
4.9% |
| Acute Myocardial Infarction |
2.4% |
| Aneurysm |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
9.8% |
| Prophylaxis |
9.3% |
| Cerebral Infarction |
8.7% |
| Diabetes Mellitus |
8.7% |
| Hypertension |
8.7% |
| Atrial Fibrillation |
6.6% |
| Cardiac Failure Chronic |
6.6% |
| Rheumatoid Arthritis |
5.5% |
| Peripheral Arterial Occlusive Disease |
4.4% |
| Cardiac Failure |
3.8% |
| Castleman's Disease |
3.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.8% |
| Prurigo |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
| Hyperuricaemia |
2.7% |
| Adenocarcinoma Pancreas |
2.2% |
| Febrile Neutropenia |
2.2% |
| Infection Prophylaxis |
2.2% |
| Pneumonia |
2.2% |
| Renal Impairment |
2.2% |
|
| Melaena |
15.2% |
| White Blood Cell Count Decreased |
12.1% |
| Blood Creatine Phosphokinase Increased |
6.1% |
| Brain Stem Haemorrhage |
6.1% |
| Pyrexia |
6.1% |
| Shock |
6.1% |
| Somnolence |
6.1% |
| Ventricular Fibrillation |
6.1% |
| Anaemia |
3.0% |
| Blood Creatinine Increased |
3.0% |
| Gastrointestinal Haemorrhage |
3.0% |
| Haematuria |
3.0% |
| Haemorrhage Subcutaneous |
3.0% |
| Hypersensitivity Vasculitis |
3.0% |
| Interstitial Lung Disease |
3.0% |
| Palpitations |
3.0% |
| Platelet Count Decreased |
3.0% |
| Pneumocystis Jirovecii Pneumonia |
3.0% |
| Puncture Site Haemorrhage |
3.0% |
| Rectal Cancer |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.9% |
| Hypertension |
11.2% |
| Prophylaxis |
10.6% |
| Cardiac Failure |
8.5% |
| Cerebral Infarction |
5.4% |
| Constipation |
4.8% |
| Rheumatoid Arthritis |
4.4% |
| Cardiac Failure Chronic |
3.8% |
| Insomnia |
3.8% |
| Cerebral Artery Embolism |
3.6% |
| Peripheral Arterial Occlusive Disease |
3.6% |
| Gastritis |
2.7% |
| Hyperphosphataemia |
2.7% |
| Osteoporosis |
2.6% |
| Pain |
2.6% |
| Glaucoma |
2.3% |
| Nephrogenic Anaemia |
2.3% |
| Angina Pectoris |
2.1% |
| Atrial Fibrillation |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
|
| Vomiting |
9.4% |
| Interstitial Lung Disease |
8.2% |
| Rhabdomyolysis |
8.2% |
| Urinary Tract Infection |
8.2% |
| Cerebral Infarction |
7.1% |
| Hepatic Function Abnormal |
5.9% |
| Renal Impairment |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| White Blood Cell Count Increased |
4.7% |
| Anaemia |
3.5% |
| Hepatitis Fulminant |
3.5% |
| Ileus |
3.5% |
| Intentional Drug Misuse |
3.5% |
| Nausea |
3.5% |
| Pneumonia |
3.5% |
| Road Traffic Accident |
3.5% |
| Urinary Incontinence |
3.5% |
| Ventricular Tachycardia |
3.5% |
| Cerebral Haemorrhage |
2.4% |
| Haematuria |
2.4% |
|
| Interacting |
| Arterial Catheterisation |
20.7% |
| Peripheral Arterial Occlusive Disease |
20.7% |
| Stent Placement |
20.7% |
| Atrial Fibrillation |
10.3% |
| Cerebrovascular Accident Prophylaxis |
10.3% |
| Non-small Cell Lung Cancer Metastatic |
5.2% |
| Cancer Pain |
3.4% |
| Hypocalcaemia |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Gastric Ulcer |
1.7% |
|
| Vascular Pseudoaneurysm |
85.7% |
| Myocardial Infarction |
14.3% |
|
